Currencies / NVAX
NVAX: Novavax Inc
6.67
USD
0.34
(4.85%)
NVAX exchange rate has changed by -4.85% for today. During the day, the instrument was traded at a low of 6.12 and at a high of 7.16.
Follow Novavax Inc dynamics. Real-time quotes will help you quickly react to market changes. By switching between different timeframes, you can monitor exchange rate trends and dynamics by minutes, hours, days, weeks, and months. Use this information to forecast market changes and to make informed trading decisions.
- M5
- M15
- M30
- H1
- H4
- D1
- W1
- MN
NVAX News
- Investing Novavax shares fall following WSJ report on FDA trial request
- Investing As FDA delays Novavax’ COVID vaccine approval, patients fight back
- GuruFocus Novavax Shares Surge 17% as FDA Requests Postmarketing Data for COVID-19 Vaccine
- Benzinga Amphenol Posts Better-Than-Expected Results, Joins SAP, Tesla, Pegasystems And Other Big Stocks Moving Higher On Wednesday - Amer Sports (NYSE:AS), Amphenol (NYSE:APH)
- Investing FDA asks Novavax for commitment on post-approval studies for COVID vaccine
- Investing Moderna, Novavax shares dip as CDC panel suggests limiting COVID shot updates
- Benzinga Novavax Covid Vaccine Shows Milder Side Effects Than Pfizer-BioNTech's Shot: Study - Novavax (NASDAQ:NVAX)
- Investing Analysis-Trump health policy uncertainty sends biotech sector into deeper slump
- Seeking Alpha Novavax: Regulatory Uncertainty Creates Risk And Opportunity
- Investing Novavax shares tumble after U.S. health secretary raises concerns over COVID shot’s efficacy
- Investor Place Sell or Buy? Here’s What Louis Is Doing After “Liberation Day”
- Benzinga Despite Headwinds, Biotech Sell-Off Could Offer Buying Opportunity: Analyst - Novavax (NASDAQ:NVAX), Sanofi (NASDAQ:SNY)
- Benzinga FDA Delays Full Approval Decision On Novavax's COVID-19 Vaccine (UPDATED) - Novavax (NASDAQ:NVAX)
- Benzinga FDA Delays Full Approval Decision On Novavax's COVID-19 Vaccine - Novavax (NASDAQ:NVAX)
- Investing FDA misses deadline for decision on Novavax’s COVID-19 vaccine, source says
- MarketWatch In a rare move, Wall Street analysts get pointed in their criticism of RFK Jr.
- Seeking Alpha FDA Shake-Up Rocks Moderna Stock As Regulatory Risks Mount (Downgrade) (MRNA)
- Benzinga Moderna, Novavax Shares Are Tumbling Monday: What's Going On? - Moderna (NASDAQ:MRNA)
- Investing Pharma stocks sink after ouster of top FDA vaccine regulator
- Seeking Alpha AbbVie Vs. Sanofi: Which Is The Better Investment Right Now (NYSE:ABBV)
- Benzinga Moderna, Novavax Shares Are Sliding Wednesday: What's Going On? - Moderna (NASDAQ:MRNA)
- Investing Factbox-Widely used drugs on US imports list from Europe
- The Motley Fool 2 Beaten-Down Stocks Near Their 52-Week Lows That Aren't Worth Buying
- Seeking Alpha Novavax, Inc. (NVAX) Leerink Partners 2025 Global Healthcare Conference (Transcript)
Daily Range
6.12
7.16
Year Range
4.29
23.86
- Previous Close
- 7.07
- Open
- 7.01
- Bid
- 6.67
- Ask
- 6.97
- Low
- 6.12
- High
- 7.16
- Volume
- 21.673 K
- Daily Change
- -4.85%
- Month Change
- 4.06%
- 6 Months Change
- -31.45%
- Year Change
- 55.48%
26 April, Saturday
00:00
ALL
- Act
- Fcst
- Prev